🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Illinois › Cicero

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Cicero, IL keessatti

Qorannoo 11 Leukemia Myeloidii Hamaa f Cicero fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • OSF Little Company of Mary Medical Center, Evergreen Park · Miili 9 fagaatti
  • Advocate Christ Medical Center, Oak Lawn · Miili 9 fagaatti
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Edward Hines Jr VA Hospital, Hines · Miili 4 fagaatti
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
  • Advocate Christ Medical Center, Oak Lawn · Miili 9 fagaatti
  • fi 2 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Edward Hines Jr VA Hospital, Hines · Miili 4 fagaatti
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Edward Hines Jr VA Hospital, Hines · Miili 4 fagaatti
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
  • Advocate Children's Hospital-Oak Lawn, Oak Lawn · Miili 9 fagaatti
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Namoota walitti qabaa jiraSadarkaa 1/2
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
  • Advocate Children's Hospital-Oak Lawn, Oak Lawn · Miili 9 fagaatti
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • Loyola University Medical Center, Maywood · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Cicero keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.